CZR Form 144: Issuer Plans 15,000‑Share Open‑Market Sale
CZR filed a Form 144 disclosing an intended sale of 15,000 shares in an open market transaction through the issuer on 11/10/2023.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
CZR filed a Form 144 disclosing an intended sale of 15,000 shares in an open market transaction through the issuer on 11/10/2023. The filing lists broker Raymond James & Associates and Nasdaq as the market.
The filing also reports securities sold during the past three months by Michael E. Pegram: 50,000 shares for $1,458,399.00 and 5,000 shares for $145,947.00, each dated 06/02/2026.
Insights
Form 144 lists an issuer open‑market sale and recent dispositions by a reported holder.
The notice shows an issuer-directed open market placement of 15,000 shares dated 11/10/2023 and two recent reported sales by Michael E. Pegram on 06/02/2026 totaling 55,000 shares with stated proceeds.
These entries are routine sale notices under the securities resale rules; cash‑flow treatment and any Rule 144 holding‑period or volume‑limitations are not specified in the excerpt.
Key Figures
Key Terms
Form 144 regulatory
Open Market market
Issuer regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does CZR's Form 144 disclose about planned sales?
Are proceeds or use of proceeds specified for the issuer sale?
AI-generated analysis. How Rhea-AI works. Not financial advice.